Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway

Journal of Clinical Psychiatry

Volumn 69, Issue 7, 2008, Pages 1099-1103

  Bramness, Jørgen G ^a,g   Skurtveit, Svetlana ^a,e   Neutel, C Ineke ^f   Mørland, Jørg ^b,c   Engeland, Anders ^a,d  

^a Division of Epidemiology   (Norway)

^b Division of Forensic Toxicology and Drug Abuse   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

^f UNIVERSITY OF OTTAWA   (Canada)

^g NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SERTRALINE; TRIMIPRAMINE; VENLAFAXINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONFIDENCE INTERVAL; DRIVER; DRUG USE; FEMALE; HUMAN; INCIDENCE; INJURY; MALE; MIGRATION; MOTOR VEHICLE; NORWAY; PRESCRIPTION; PRIORITY JOURNAL; REGISTRATION; RISK ASSESSMENT; RISK FACTOR; SEDATION; TRAFFIC ACCIDENT;

EID: 47749100049     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0709     Document Type: Article

References (33)

1. US Department of Health and Human Services. Health, United States, 2006: With Cbartbook on Trends in the Health of Americans. Hyattsville, Md: National Center for Health Statistics; 2006
2. Bramncss JG. Hausken AM, Sakshaug S, et al. Prescription of selective serotonin reuptake inhibitors 1990-2004. Tidsskr Nor Laegeforen 2005; 125:2470-2473
3. Ramaekers JG, Muntjewerff ND, O'Hanlon JF. A comparative study of acute and subchronic effects of dothiepin. fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 1995; 39:397-404
4. Linnoila M, Seppala T. Antidepressants and driving. Accid Anal Prev 1985;17:297-301
5. Robbe HW, O'Hanlon JE Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol 1995; 5:35-42
6. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 2003;64:20-29
7. van Laar MW, van Willigenburg AP, Volkerts F,R. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol 1995;15:30-40
8. O'Hanlon JF, Robbe HW, Vermeeren A, et al. Venlalaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol 1998;18:212-221
9. Ramaekers JG, Swijgman HF, O'Hanlon JF. Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacology (Berl) 1992;106 (suppl):S62-S67
10. Alvarez F, Prada R, Del Rio M. Drugs and alcohol consumption amongst Spanish drivers. Forensic Sci Int 1992;53:221-225
11. Gjerde H. Beylich KM, Mørland J. Incidence of alcohol and drugs in fatally injured car drivers in Norway. Accid Anal Prev 1993;25:479-483
12. Eogan BK, Schwilke F.W. Drug and alcohol use in fatally injured drivers in Washington State. J Forensic Sci 1996;41:505-510
13. Currie D. Hashemi K, Fothergill J, et al. The use of antidepressants and benzodiazepines in the perpetrators and victims of accidents. Occup Med (Lond) 1995;45:323-325
14. Leveille SG. Buchner DM, Koepsell TD, et al. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 1994;5:591-598
15. Barbone F. McMahonAD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998;352:1331-1336
16. Hobi V, Gastpar M, Gastpar G, et al. Driving ability of depressive patients under antidepressants. J Int Med Res 1982;10:65-81
17. Brunnauer A. Laux G. Geiger E, et al. Antidepressants and driving ability: results from a clinical study. J Clin Psychiatry 2006;67:1776-1781
18. Gerhard U, Hobi V. Cognitive-psychomotor functions with regard to fitness for driving of psychiatric patients treated with neuroleptics and antidepressants. Ncuropsychobiology 1984;12:39-47
19. Bramness JG, Skurtveit S, Mørland J, et al. The risk of traffic accidents after prescriptions of carisoprodol. Accid Anal Prev 2007;39:1050-1055
20. Engeland A, Skurtveit S. Mørland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol 2007;17:597-602
21. Furu K. Drug utilisation in a public health perspective: establishing a national prescription register in Norway. Nor J Epidemiol 2001;11:55-60
22. Bramness JG, Furu K, Engeland A. et al. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study. Br J Clin Pharmacol 2007; 64:210-218
23. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo, Norwav: WHO; 2005
24. Statistics Norway. Road traffic accidents involving personal injury, December 2007. Available at: http://www.ssb.no/english/subjects/10/12/20/ vtu_en/arkiv/. Accessibility verified January 29. 2008
25. Hammer H. The central population registry in medical research [in Norwegian]. Tidsskr Nor Lægeforen 2002;122:2550
26. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995;5:239-244
27. Strom B. Pharmacoepidemiology. Chichester, United Kingdom: John Wiley & Sons, Ltd; 2000
28. Sondergard L. Kvist K, Andersen PK, et al. Do antidepressants prevent suicide? Int Clin Psychopharmacol 2006;21:211-218
29. Movig KL, Mathijssen MP, Nagel PH, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 2004;36: 631-636
30. Longo MC, Lokan RJ, White JM. The relationship between blood benzodiazepine concentration and vehicle crash culpability. J Traffic Med 2001;29:36-43
31. Longo MC, Hunter CE, Lokan RJ. et al. The prevalence of alcohol, cannabinoids. benzodiazepines and stimulants amongst injured drivers and their role in driver culpability, pt 2: the relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 2000;32:623-632
32. Terhune K.W. An evaluation of responsibility analysis for assessing alcohol and drug crash effects. Accid Anal Prev 1983; 15:237-246
33. Robertson MD, Drummer OH. Responsibility analysis: a methodology to study the effects of drugs in driving. Accid Anal Prev 1994;26:243-247